The timing of this presentation should coincide with data from the Shionogi drug. They announced completion of enrollment in December but said the trial would be kept blinded for 3 months to get 12 week data on symptoms for a look on drug effect on long covid (they are planning to follow patients for 6 months total).
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.